Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder

✍ Scribed by Leslie Citrome; Christopher Reist; Liisa Palmer; Leslie B. Montejano; Gregory Lenhart; Brian Cuffel; James Harnett; Kafi N. Sanders

• Book ID: 119364340
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 300 KB
• Volume: 115
• Category: Article
• ISSN: 0920-9964
• DOI: 10.1016/j.schres.2009.09.023